Global Hydrophilic Intermittent Urinary Catheter Market Strategic Research Report
By Type: Ready-to-use, Water-activated Type
By Application: Neurogenic Bladder, Postoperative/Acute Urinary Retention, Others
Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America
Key Players: Becton Dickinson, Convatec, Wellspect, Hollister Incorporated, Teleflex, Well Lead Medical Co., Ltd., Coloplast, Boen Healthcare Co., Ltd, Bevermedical, AdvaCare Pharma, GCMEDICA, Bonree Medical Co., Ltd, Manfred Sauer GMBH, Otsuka Pharmaceutical Factory, Inc., Daxan
Обзор
Scope of the Report
The global Hydrophilic Intermittent Urinary Catheter market size is predicted to grow from US$ 5,635 million in 2025 to US$ 11,807 million in 2032; it is expected to grow at a CAGR of 11.2% from 2026 to 2032.
In 2025, global sales of hydrophilic intermittent urinary catheters reached 1.8 billion units, with an average selling price of US$3.2 per unit. Hydrophilic intermittent urinary catheters are disposable medical consumables with a hydrophilic coating. Before use, they form a lubricating layer upon contact with water, significantly reducing insertion friction and minimizing the risk of urethral injury and infection. They are widely used for patients with neurogenic bladder, postoperative voiding disorders, and those requiring long-term voiding management. Upstream raw materials mainly include medical-grade PVC or TPU tubing, hydrophilic coating materials (PVP, etc.), lubricants, and sterile packaging materials. Downstream supply relationships are primarily with hospital urology departments, rehabilitation institutions, and home care channels. In 2025, global total production capacity was approximately 2.2 billion units, with an industry average capacity utilization rate of approximately 82% and an overall gross profit margin of approximately 40%. Demand and opportunity analysis shows that the accelerated aging of the global population, the increase in patients with neurological diseases and chronic urinary dysfunction, and the increased emphasis on quality of life and infection control are continuously driving the demand for hydrophilic intermittent urinary catheters. In the future, there are clear long-term growth and high-value-added business opportunities in terms of high-comfort design, models specifically for women and children, and expansion into home care channels.
The hydrophilic intermittent urinary catheter market is experiencing steady growth, driven by an aging population, an increasing number of patients with chronic urinary dysfunction, and growing emphasis on infection control and patient comfort in healthcare institutions. Compared to traditional catheters, the hydrophilic coating significantly reduces insertion friction and the risk of urinary tract infections, making it a standard choice in hospitals, rehabilitation facilities, and home care.
Future market competition will focus on product comfort, material safety, and functional diversification, including innovative products such as women's-specific, children's-specific, and visualized catheters. High-end coating technology and the convenience of single-use will be key to enhancing brand recognition and customer loyalty. With the development of home care, chronic disease management, and telemedicine, the hydrophilic intermittent urinary catheter market has enormous potential beyond hospitals, exhibiting sustained growth and high-value-added upgrade potential in the long term, making it an important sub-segment of the urological consumables field.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hydrophilic Intermittent Urinary Catheter market?
What factors are driving Hydrophilic Intermittent Urinary Catheter market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hydrophilic Intermittent Urinary Catheter market opportunities vary by end market size?
How does Hydrophilic Intermittent Urinary Catheter break out by Type, by Application?
This report presents a comprehensive overview of the global Hydrophilic Intermittent Urinary Catheter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.
Segment by Type
- Ready-to-use
- Water-activated Type
Segment by Material
- Polyvinyl Chloride Catheters
- Medical-grade Silicone Catheters
- Polyurethane Catheters
Segment by Sizes
- Sizes: 6Fr - 10Fr
- Sizes: 12Fr - 14Fr
- Others
Segment by Application
- Neurogenic Bladder
- Postoperative/Acute Urinary Retention
- Others
Who Can Use This Report?
This report is written for decision-makers who need a clear, data-backed view of the global Hydrophilic Intermittent Urinary Catheter market:
- Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
- Distributors, channel partners and end users in Neurogenic Bladder, Postoperative/Acute Urinary Retention, Others evaluating demand and sourcing options
- Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
- Government agencies, industry associations and research institutions tracking industry developments and policy impact
Market snapshot
Global Hydrophilic Intermittent Urinary Catheter Market Strategic Research Report snapshot, 2025–2032
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.Segments covered in this report
Table of contents
01Executive Summary
02Industry Overview & Forecast
- 2.1.1 Market Definition and Scope
- 2.1.2 Market Size and Growth Forecast
- 2.1.3 Volume Analysis
- 2.1.4 Segment Outlook by Type
- 2.1.5 Segment Outlook by Application
- 2.1.6 Regional Outlook
- 2.1.7 Structural Developments Shaping the Forecast
- 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
- 3.1 Market Segmentation by Type
- 3.1.1 Market by Type Overview
- 3.1.2 Ready-to-use
- 3.1.3 Water-activated Type
- 3.1.4 Volume Analysis
04Market Segmentation by Application
- 4.1 Market Segmentation by Application
- 4.1.1 Market by Application Overview
- 4.1.2 Neurogenic Bladder
- 4.1.3 Postoperative/Acute Urinary Retention
- 4.1.4 Others
- 4.1.5 Volume Analysis
05Regional Market Forecast
- Asia Pacific
- North America
- Europe
- Middle East & Africa
- Latin America
06Country-Level Market Forecast
- 6.1 Asia Pacific
- 6.1.1 China
- 6.1.2 Japan
- 6.1.3 Korea
- 6.1.4 Southeast Asia
- 6.1.5 India
- 6.1.6 Australia
- 6.1.7 Rest of Asia Pacific
- 6.2 North America
- 6.2.1 United States
- 6.2.2 Canada
- 6.2.3 Mexico
- 6.2.4 Rest of North America
- 6.3 Europe
- 6.3.1 Germany
- 6.3.2 France
- 6.3.3 UK
- 6.3.4 Italy
- 6.3.5 Russia
- 6.3.6 Rest of Europe
- 6.4 Middle East & Africa
- 6.4.1 Egypt
- 6.4.2 South Africa
- 6.4.3 Israel
- 6.4.4 Turkey
- 6.4.5 GCC Countries
- 6.4.6 Rest of Middle East & Africa
- 6.5 Latin America
- 6.5.1 Brazil
- 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
- 7.1 Growth Drivers & Inhibitors
- 7.1.1 Section Overview
- 7.1.2 Growth Drivers
- 7.1.3 Growth Inhibitors
- 7.1.4 Driver and Inhibitor Impact Assessment
- 7.1.5 Analyst Perspective
08Key Company Profiles
- 8.1 Becton Dickinson
- 8.1.1 Company Overview
- 8.1.2 Key Products & Segments
- 8.1.3 Financial Performance (2023–2025)
- 8.1.4 Business Strategy
- 8.1.5 SWOT Analysis
- 8.1.6 Strategic Implications (2026–2032)
- 8.2 Convatec
- 8.2.1 Company Overview
- 8.2.2 Key Products & Segments
- 8.2.3 Financial Performance (2023–2025)
- 8.2.4 Business Strategy
- 8.2.5 SWOT Analysis
- 8.2.6 Strategic Implications (2026–2032)
- 8.3 Wellspect
- 8.3.1 Company Overview
- 8.3.2 Key Products & Segments
- 8.3.3 Financial Performance (2023–2025)
- 8.3.4 Business Strategy
- 8.3.5 SWOT Analysis
- 8.3.6 Strategic Implications (2026–2032)
- 8.4 Hollister Incorporated
- 8.4.1 Company Overview
- 8.4.2 Key Products & Segments
- 8.4.3 Financial Performance (2023–2025)
- 8.4.4 Business Strategy
- 8.4.5 SWOT Analysis
- 8.4.6 Strategic Implications (2026–2032)
- 8.5 Teleflex
- 8.5.1 Company Overview
- 8.5.2 Key Products & Segments
- 8.5.3 Financial Performance (2023–2025)
- 8.5.4 Business Strategy
- 8.5.5 SWOT Analysis
- 8.5.6 Strategic Implications (2026–2032)
- 8.6 Well Lead Medical Co.,Ltd.
- 8.6.1 Company Overview
- 8.6.2 Key Products & Segments
- 8.6.3 Financial Performance (2023–2025)
- 8.6.4 Business Strategy
- 8.6.5 SWOT Analysis
- 8.6.6 Strategic Implications (2026–2032)
- 8.7 Coloplast
- 8.7.1 Company Overview
- 8.7.2 Key Products & Segments
- 8.7.3 Financial Performance (2023–2025)
- 8.7.4 Business Strategy
- 8.7.5 SWOT Analysis
- 8.7.6 Strategic Implications (2026–2032)
- 8.8 Boen Healthcare Co., Ltd
- 8.8.1 Company Overview
- 8.8.2 Key Products & Segments
- 8.8.3 Financial Performance (2023–2025)
- 8.8.4 Business Strategy
- 8.8.5 SWOT Analysis
- 8.8.6 Strategic Implications (2026–2032)
- 8.9 Bevermedical
- 8.9.1 Company Overview
- 8.9.2 Key Products & Segments
- 8.9.3 Financial Performance (2023–2025)
- 8.9.4 Business Strategy
- 8.9.5 SWOT Analysis
- 8.9.6 Strategic Implications (2026–2032)
- 8.10 AdvaCare Pharma
- 8.10.1 Company Overview
- 8.10.2 Key Products & Segments
- 8.10.3 Financial Performance (2023–2025)
- 8.10.4 Business Strategy
- 8.10.5 SWOT Analysis
- 8.10.6 Strategic Implications (2026–2032)
- 8.11 GCMEDICA
- 8.11.1 Company Overview
- 8.11.2 Key Products & Segments
- 8.11.3 Financial Performance (2023–2025)
- 8.11.4 Business Strategy
- 8.11.5 SWOT Analysis
- 8.11.6 Strategic Implications (2026–2032)
- 8.12 Bonree Medical Co., Ltd
- 8.12.1 Company Overview
- 8.12.2 Key Products & Segments
- 8.12.3 Financial Performance (2023–2025)
- 8.12.4 Business Strategy
- 8.12.5 SWOT Analysis
- 8.12.6 Strategic Implications (2026–2032)
- 8.13 Manfred Sauer GMBH
- 8.13.1 Company Overview
- 8.13.2 Key Products & Segments
- 8.13.3 Financial Performance (2023–2025)
- 8.13.4 Business Strategy
- 8.13.5 SWOT Analysis
- 8.13.6 Strategic Implications (2026–2032)
- 8.14 Otsuka Pharmaceutical Factory, Inc.
- 8.14.1 Company Overview
- 8.14.2 Key Products & Segments
- 8.14.3 Financial Performance (2023–2025)
- 8.14.4 Business Strategy
- 8.14.5 SWOT Analysis
- 8.14.6 Strategic Implications (2026–2032)
- 8.15 Daxan
- 8.15.1 Company Overview
- 8.15.2 Key Products & Segments
- 8.15.3 Financial Performance (2023–2025)
- 8.15.4 Business Strategy
- 8.15.5 SWOT Analysis
- 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
- 9.1 Competitive Landscape Overview
- 9.2 Competitive Intensity Assessment
- 9.3 Key Player Strategies & Positioning
- 9.4 Competitive Dynamics & Strategic Outlook
- 9.4.1 Emerging Competitive Threats
- 9.4.2 Consolidation vs. Fragmentation Outlook
- 9.4.3 Competitive Response Matrix
- 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
- 10.1 Threat of New Entrants
- 10.2 Bargaining Power of Buyers
- 10.3 Bargaining Power of Suppliers
- 10.4 Threat of Substitutes
- 10.5 Competitive Rivalry
11PESTLE Analysis
- 11.1 Political
- 11.2 Economic
- 11.3 Social and Demographic
- 11.4 Technological
- 11.5 Legal and Regulatory
- 11.6 Environmental
- 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
- 13.1 Future Trends & Outlook
- 13.1.1 Trend Summary and Commercial Maturity Assessment
- 13.1.2 Technology and Innovation Trends
- 13.1.3 Long-Term Market Outlook
- 13.1.4 Investment & M&A Activity Outlook
- 13.1.5 Overall Outlook Assessment
Frequently asked questions
How big is the global Hydrophilic Intermittent Urinary Catheter market?
How fast is the Hydrophilic Intermittent Urinary Catheter market expected to grow?
What does the Hydrophilic Intermittent Urinary Catheter market cover?
What are the main segments of the Hydrophilic Intermittent Urinary Catheter market by type?
Which applications drive demand in the Hydrophilic Intermittent Urinary Catheter market?
Who are the key players in the Hydrophilic Intermittent Urinary Catheter market?
Which regions and countries are covered for Hydrophilic Intermittent Urinary Catheter?
What is driving growth in the Hydrophilic Intermittent Urinary Catheter market?
Who should buy the Hydrophilic Intermittent Urinary Catheter market report?
What license options are available for this report?
Research Methodology
All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.
Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.
Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.
Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.
CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.
All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.
On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.
Need a customized version?
Get country-, segment- or company-specific intelligence tailored to your exact requirements.
Request custom research →Request a free sample
Receive a sample of Global Hydrophilic Intermittent Urinary Catheter Market Strategic Research Report before you buy.
Customize This Report
Describe your specific requirements and our analysts will scope and deliver a tailored version.
Request Invoice
We will email a proforma invoice within 24 hours. Report access is granted upon payment confirmation.
Navadhi Market Research · Healthcare & Medical Devices